NATIONAL INCUBATOR SHIFTS INTO GEAR, ANNOUNCING VACCINE AND INFECTIOUS DISEASE INNOVATION COHORT Six Australian infectious disease innovations receive $10.48 million to accelerate commercialisation potential
With
Jenny Herz,
Co-Founder and Executive Director
Biointelect
Danielle Shand,
General Manager
Biointelect Venturer
SEGMENT
Filmed in Sydney | September 2026
Biointelect Venturer is Australia’s national incubator for infectious disease innovation, helping promising Australian scientific innovators accelerate their path from discovery to impact. Funded by the Australian Government’s Medical Research Future Fund (MRFF) through the 2024 BioMedTech Incubator grant opportunity, Biointelect Venturer combines catalytic non-dilutive funding with commercialisation expertise, strategic guidance, networks and tailored support to progress early-stage innovations towards commercial and investment readiness. Managed and operated by Biointelect, the incubator builds on Biointelect’s deep expertise and success in supporting early-stage biotech and medtech commercialisation.
Biointelect Venturer has announced six Australian infectious disease innovations will share $10.48 million in the incubator’s first funding round giving the successful research teams the ability to advance their early-stage breakthroughs to commercial and investment readiness.
– AdaptiVax Pty Ltd
– Ebivanta Therapeutics Pty Ltd
– ENA Respiratory Pty Ltd
– Proboxis Biotechnology Pty Ltd
– Saccharide Therapeutics Pty Ltd
– SAMMvax Pty Ltd
The recipients address significant local and global unmet health needs in infectious disease and include three vaccine offerings, a unique nasal antiviral technology and two vaccine platform technologies.
The projects will now enter the Biointelect Venturer incubation program for up to two years and receive non-dilutive funding, tailored commercialisation support, expert mentoring and access to national and international networks to help progress their technologies to secure commercial interest and funding.
Biointelect Venturer was established through a $32.9 million Medical Research Future Fund (MRFF) grant from the Australian Government’s MRFF Medical Research Commercialisation initiative. It will support two national cohort intakes, this being the first, and a dedicated top-up round for high-potential projects as part of the program.
Biointelect Venturer is helping to build local capability in translational research and commercialisation and supporting the creation and growth of Australian biotech companies developing health technologies across the infectious disease sector. Ultimately the ambition is to strengthen Australia’s position as a global infectious disease innovation hub.
Source: Adapted from Biointelect media release (August 2026)
-
Health Minister’s Awards for Nursing Trailblazers
An ACT nurse dedicated to giving people more dignity and choice in their final days was earlier this week night named the inaugural Health Minister’s Nursing Trailblazer at an awards ceremony in Sydney.
Lord Nigel Crisp, Co-Chair Nursing Now and Australian College of Nursing President, Professor Christine Duffield FACN presented the inaugural Health Minister’s Nursing Trailblazer Award to Nikki Johnston MACN, a Palliative Care Nurse Practitioner based in Canberra at Calvary Health Care’s Clare Holland House.
-
Values in Workplace Culture
Professor Sabe Sabesan, is the Clinical Dean of the Townsville Regional Medical Training network incorporating the Townsville Hospital and Health Services and the Townsville Clinical School of the James Cook University and the director of the department of Medical oncology at the Townsville Cancer Centre, Townsville Hospital.
The Professor recently wrote, “Workforce wellness and engagement have become buzzwords in healthcare settings since there is an intimate relationship between staff wellbeing and performance of the healthcare system. Wellness initiatives such as wellness champions and wellness committees have been set up in response to emerging workforce mental health issues. These are largely reactive rather than being proactive in addressing or preventing the root cause of mental health issues.”
-
The next era of dental care
In September 2026, the Royal Australasian College of Dental Surgeons returned with its bi-annual, Fine Edge of Dentistry 2026 Conference.
The conference was held is Sydney and was also an opportunity to honour recent outstanding contributions and achievements from College Members and Fellows, within the curated scientific program.
